Physician

Volkan Sumer, DO

According to 2025 Medicare claims, Volkan Sumer, DO (NPI: 1730185125) practices family practice in the Peoria, IL market, with the plurality of this provider's patient population coming from Tazewell, IL. This provider's primary affiliated billing organization is ILLINOIS CENTERS FOR PAIN AND REHAB, SC (NPI: 1689860975; TIN: 371404312) and primary practice location at 61554-6241.

Sumer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,016 traditional Medicare patients, billed 40,868 HCPCS/CPT codes, and received $506,284 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 13,936 prescription claims across 1,049 beneficiaries totaling $815,197 in drug costs, led by Eliquis (Apixaban). DME data shows 507 claims. Open Payments data shows 18 records totaling $438. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $721,308 to $506,284. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $62,334 and ending at $28,512.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,045	24,331	$721,308
2016	1,170	24,230	$733,357
2017	1,176	33,425	$649,205
2018	1,148	35,919	$536,231
2019	1,066	30,637	$564,918
2020	1,239	39,261	$557,653
2021	988	36,850	$616,234
2022	1,011	35,100	$432,639
2023	830	27,249	$318,149
2024	1,016	40,868	$506,284

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	765	15,224	$922,026
2016	885	18,202	$1,053,592
2017	953	20,168	$1,098,007
2018	1,016	21,100	$1,260,755
2019	1,030	18,503	$1,166,321
2020	996	16,323	$1,086,093
2021	1,008	15,219	$1,007,533
2022	1,004	13,601	$888,978
2023	981	13,031	$888,911
2024	1,049	13,936	$815,197

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	195	790	$39,426
2016	306	878	$48,832
2017	353	1,004	$59,123
2018	408	1,172	$48,982
2019	379	1,185	$25,833
2020	314	1,041	$29,849
2021	219	706	$23,460
2022	171	670	$29,290
2023	172	551	$27,812
2024	154	507	$24,599

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	462	462	$116
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	679	1,108	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	470	802	$56
83036	Hemoglobin a1c level	428	749	$9
36415	Insertion of needle into vein for collection of blood sample	496	836	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	206	8,383	$163,083
Jardiance	Empagliflozin	48	2,492	$46,286
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	53	2,130	$45,242
Januvia	Sitagliptin Phosphate	44	2,220	$41,773
Xarelto	Rivaroxaban	45	2,010	$37,005

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	21	$8,469
A7031	Face mask interface, replacement for full face mask, each	N	12	29	$2,767
A7030	Full face mask used with positive airway pressure device, each	N	13	30	$2,739
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	22	48	$1,880
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	47	$1,229

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$438	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Volkan Sumer, DO?

Tedicare shows public-source Medicare data for Volkan Sumer, DO (NPI 1730185125), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Volkan Sumer, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Volkan Sumer, DO?

Volkan Sumer, DO is linked to ILLINOIS CENTERS FOR PAIN AND REHAB, SC (billing NPI 1689860975) in the available physician profile data.

Does Volkan Sumer, DO have Open Payments data?

Volkan Sumer, DO has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.